Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP141387.RAYBwOBKAqcgQvHarxDkEPo9VJW3c0V8T0cxr9YJP8ozc130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP141387.RAYBwOBKAqcgQvHarxDkEPo9VJW3c0V8T0cxr9YJP8ozc130_assertion type Assertion NP141387.RAYBwOBKAqcgQvHarxDkEPo9VJW3c0V8T0cxr9YJP8ozc130_head.
- NP141387.RAYBwOBKAqcgQvHarxDkEPo9VJW3c0V8T0cxr9YJP8ozc130_assertion description "[We identified individuals with CYP2C9*2 and CYP2C9*3 genotypes (>or=1 variant allele) in the Adenoma Prevention with Celecoxib trial.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP141387.RAYBwOBKAqcgQvHarxDkEPo9VJW3c0V8T0cxr9YJP8ozc130_provenance.
- NP141387.RAYBwOBKAqcgQvHarxDkEPo9VJW3c0V8T0cxr9YJP8ozc130_assertion evidence source_evidence_literature NP141387.RAYBwOBKAqcgQvHarxDkEPo9VJW3c0V8T0cxr9YJP8ozc130_provenance.
- NP141387.RAYBwOBKAqcgQvHarxDkEPo9VJW3c0V8T0cxr9YJP8ozc130_assertion SIO_000772 19233181 NP141387.RAYBwOBKAqcgQvHarxDkEPo9VJW3c0V8T0cxr9YJP8ozc130_provenance.
- NP141387.RAYBwOBKAqcgQvHarxDkEPo9VJW3c0V8T0cxr9YJP8ozc130_assertion wasDerivedFrom gad-20150221 NP141387.RAYBwOBKAqcgQvHarxDkEPo9VJW3c0V8T0cxr9YJP8ozc130_provenance.
- NP141387.RAYBwOBKAqcgQvHarxDkEPo9VJW3c0V8T0cxr9YJP8ozc130_assertion wasGeneratedBy ECO_0000203 NP141387.RAYBwOBKAqcgQvHarxDkEPo9VJW3c0V8T0cxr9YJP8ozc130_provenance.